Genki Drug Stores achieved sales of 220.9 billion yen (up 10.6% YoY) for the fiscal year ending June 2026, maintaining increased revenue and profit. The company plans to continue proactive store expansion and operational efficiencies.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"9267","jir_company_name":"Genki Drug Stores Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-07-28","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/9267-20260728-03.pdf","jir_short_summary":"Genki Drug Stores achieved sales of 220.9 billion yen (up 10.6% YoY) for the fiscal year ending June 2026, maintaining increased revenue and profit. The company plans to continue proactive store expansion and operational efficiencies.","jir_summary":"### Performance Overview\nGenki Drug Stores achieved sales of 220.9 billion yen (up 10.6% YoY) for the fiscal year ending June 2026, continuing its growth in revenue and profit. Operating income was 10,985 million yen (+9.2%), and net income was 8,785 million yen (+4.1%), establishing a stable earnings foundation. Through new store openings and efficiency improvements at existing stores, the company aims to enhance profitability and will continue to promote active store expansion and management efficiency measures.\n\n### Future Outlook and Strategies\nThe company will continue expanding store openings and renovating existing stores, reinforcing its community-oriented store network. Additionally, it will invest in IT to improve operational efficiency and expand product lineup to enhance customer satisfaction. For the full-year forecast for June 2027, sales are expected to reach 244.0 billion yen (+10.6%), with operating income of 12,000 million yen (+9.2%), aiming for sustainable growth.","jir_financial_highlights":"Sales: 220.9 billion yen (YoY +10.6%)\nOperating Income: 10,985 million yen (YoY +9.2%)\nNet Income: 8,785 million yen (YoY +4.1%)","jir_category":"","jir_hashtags":"#GenkiDrugStores, #EarningsReport, #JapaneseStocks","jir_key_figures":"Sales: 220.9 billion yen (+10.6% YoY)\nOperating Income: 10,985 million yen (+9.2% YoY)\nNet Income: 8,785 million yen (+4.1% YoY)","jir_meta_title":"\u3010Genki Drug Stores\u3011Fiscal Year June 2026 Earnings Report \uff5c Sales of 220.9 billion yen (+10.6%)","jir_meta_description":"Genki Drug Stores achieved sales of 220.9 billion yen (up 10.6% YoY) for the fiscal year June 2026, continuing revenue and profit growth. The company plans to proceed with active store expansion and efficiency improvements.","jir_og_title":"Genki Drug Stores June 2026 Earnings \uff5c Sales of 220.9 billion yen Growth in Revenue and Profit","jir_og_description":"Genki Drug Stores is expected to continue growth, having achieved sales of 220.9 billion yen (+10.6%) for the fiscal year ending June 2026.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[]","ir_related_company":9174,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-88913","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n